Back to Man Group plc Man Group plc

STOKSTOK
7 quarters

Position history for Man Group plcMan Group plc's holdings in STOKE THERAPEUTICS INC

No. Man Group exited its STOK (Stoke Therapeutics) position in Q1 2024. Its Q4 2023 13F listed 15,361 shares worth $80,799. Man Group first reported STOK in Q3 2022 and held it in 5 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$808,000

Total Shares Change

-62,939

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2024-Q1
Latest
Exited
0
-100.0%
$00.0%$13.50
0
2023-Q4
Decreased
15,361
-86.5%
$80,7990.0%$5.26
0
2023-Q3
Increased
113,540
+17.6%
$447,3480.0%$3.94
28
2023-Q2
Decreased
96,554
-7.9%
$1M0.0%$10.50
0
2023-Q1
New
104,789
-
$872,8920.0%$8.14
34
2022-Q4
Exited
0
-100.0%
$00.0%$9.23
0
2022-Q3
New
62,939
-
$808,0000.0%$13.02
34

Other major holders of STOK: FMR LLC, RTW INVESTMENTS, LP, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used